U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
EMIBETUZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
emibetuzumab [INN]
Preferred Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .KAPPA.-CHAIN, DIMER
Common Name English
LY2875358
Code English
LA480
Code English
LA-480
Common Name English
LY-2875358
Code English
Emibetuzumab [WHO-DD]
Common Name English
C-8H241
Code English
EMIBETUZUMAB [USAN]
Common Name English
Code System Code Type Description
FDA UNII
MO4K3GDN1I
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
SMS_ID
100000170769
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
CAS
1365287-97-3
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
DRUG BANK
DB11849
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109517
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL3301578
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
NCI_THESAURUS
C95732
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
USAN
AB-67
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
INN
9932
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
WIKIPEDIA
Emibetuzumab
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
EVMPD
SUB184908
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
ACTIVE MOIETY
EMIBETUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966